The import of medicaments for therapeutic, prophylactic use to Brazil has exhibited fluctuating trends over the years. In 2023, imports stood at 3.7908 Billion US Dollars, representing a year-on-year increase of 1.82%. Over the last five years, the compound annual growth rate (CAGR) has averaged 1.76%. Future forecasts indicate steady growth, with imports expected to reach 4.1173 Billion US Dollars by 2028, reflecting a forecasted five-year CAGR of 1.23% and overall growth of 6.32%.
Key points to note:
- Imports in 2023: 3.7908 Billion US Dollars
- Year-on-year growth in 2023: 1.82%
- 5-year historical CAGR (2019-2023): 1.76%
- 5-year forecast CAGR (2024-2028): 1.23%
- Projected value in 2028: 4.1173 Billion US Dollars
Future trends to watch for include potential regulatory changes, shifts in trade policies, and advancements in pharmaceutical technology which could impact import dynamics. Additionally, economic conditions in Brazil and global healthcare developments will play significant roles in shaping the market landscape.
